+++thanks for 3 articles_Request for 4 articles

[pendyala123]

1.Title: JAK inhibitors and other novel agents in myeloproliferative neoplasms: are we hitting the target?
Authors: Nicole Kucine and Ross L. Levine

Journal: Therapeutic Advances in Hematology August 2011 2: 203-211, first published on June 15, 2011

DOI:

http://dx.doi.org/10.1177/2040620711410095

link:

Код: Выделить всё

http://tah.sagepub.com/content/2/4/203.full.pdf+html

2.title: JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
Authors: A Pardanani, A M Vannucchi, F Passamonti, F Cervantes, T Barbui and A Tefferi
Journal: Leukemia 25: 218-225; advance online publication, November 16, 2010;

DOI:

http://dx.doi.org/10.1038/leu.2010.269

link:

Код: Выделить всё

http://www.nature.com/leu/journal/v25/n2/pdf/leu2010269a.pdf

3.title: Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasms
Authors: Stein, Brady L.; Crispino, John D.; Moliterno, Alison R.
Journal: Current Opinion in Oncology. 23(6):609-616, November 2011.

DOI:

http://dx.doi.org/10.1097/CCO.0b013e32834d1b22

link:

Код: Выделить всё

http://journals.lww.com/co-oncology/toc/2011/11000

4.Title: The many faces of Janus kinase
Authors: Matthew M. Seavey, Pawel Dobrzanski
journal: Biochemical Pharmacology (2012), 83(9), 1136-1145

DOI:

http://dx.doi.org/10.1016/j.bcp.2011.12.024

link:

Код: Выделить всё

http://www.sciencedirect.com/science/article/pii/S0006295211009403

[surius]

2,4

[kms]

[Chem_DM]

Rules, paragraph 2!